Skip to content
Search

Latest Stories

Boots closes two more stores for good

Boots closes two more stores for good

The retailer is closing more stores this year to reduce its UK store portfolio from around 2,200 to 1,900

High street pharmacy giant Boots permanently shut down two more branches on Saturday (March 16) as it moves forward with its plan to close 300 stores.


The Wrightson House branch at the Pavilion Shopping Centre in Teesside and the Aslake Close pharmacy in Sprowston were closed for good, according to BirminghamLive.

The pharmacy giant and chemist announced that all their prescriptions from its branch in Sprowston will be moved to Lawson Road Health Centre, with the nearest Boots branches located in London Street and Aylsham Road.

The closure of the branch at the Pavilion Shopping Centre in Teesside was confirmed to the public with a notice placed in the shop window, informing customers about nearby Boots stores to collect their prescriptions.

The notice reads: "We are closing. This store will close, on March 16, 2024. Your nearest store for collecting prescriptions will be Thornaby Health Centre, Trenchard Avenue, TS17 OEE. Other stores nearby are: 12-14 High Street, Teesside Retail Park, Norton, TS20 1DN 21B Goodwood Square, TSI7 7BW.”

In July 2023, the retailer announced its decision to close 300 branches located “in close proximity to each other” to reduce its UK store portfolio from around 2,200 to 1,900.

In January, the retail giant closed two branches in Kent and one in Glasgow. A Boots pharmacy in St James’s Street, Brighton was also closed permanently on 20 January after serving the community for more than a century.

Cornish & Devon Post had in January reported that the Boots pharmacy on Bell Lane adjacent to the Stillmoor House building of Bosvena Health will close on March 25.

Last month, Boots and the Pharmacists’ Defence Association (PDA) Union confirmed a pay increase for trainee pharmacists in England and Northern Ireland.

The hourly pay rate for trainee pharmacists working at Boots pharmacies will be £12.69 for Zone A in England/Northern Ireland, £13.79 for Zone B in England and £14.05 for Zone C in England from 1 April 2024.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less